GLP-1S Peptide Research Overview
GLP-1S is a high-purity, research grade glucagon like peptide 1 developed for laboratory investigation of metabolic regulation, incretin signaling, glucose homeostasis, and energy balance. The compound is based on the active fragment of endogenous GLP-1 with structural modifications that improve stability. It serves as a defined tool for studying pancreatic beta-cell function, hypothalamic control of feeding, gastrointestinal motility, and metabolic responses in experimental systems. GLP-1S is intended solely for research purposes.

Molecular Composition and Mechanistic Profile

• GLP-1S (Glucagon-Like Peptide-1 Analog): A synthetic peptide modeled on the naturally occurring incretin hormone GLP-1(7-36)amide or GLP-1(7-37), produced from proglucagon in intestinal L-cells. GLP-1S binds with high affinity to the GLP-1 receptor (GLP-1R, a class B G-protein-coupled receptor) and acts as an agonist in preclinical models. It is provided strictly for research use only.

• Structural characteristics: GLP-1S retains the alpha-helical region necessary for receptor binding and includes modifications that reduce susceptibility to DPP-4 cleavage. This supports good solubility and stability in aqueous buffers for use in in vitro, ex vivo, and in vivo research models. Studies show that GLP-1S stimulates glucose-dependent insulin secretion, suppresses glucagon release from pancreatic alpha cells, slows gastric emptying, and influences satiety signaling via the central nervous system. It also affects lipid metabolism and inflammatory markers in experimental systems. All work with GLP-1S is for research purposes only.

Integrated Research Applications

• GLP-1S is used in research to examine incretin biology, receptor signaling, and metabolic control. Typical research areas include:

• In vitro studies using cell lines or isolated islets to measure insulin secretion, beta-cell viability, cAMP signaling, and responses to metabolic stress.

• Ex vivo preparations of pancreatic or gastrointestinal tissue to assess hormone release and motility under controlled conditions.

• In vivo preclinical models investigating glucose regulation, body weight, cardiovascular parameters, and inflammatory responses through GLP-1R pathways, hypothalamic signaling, and cytokine modulation.

Using a single characterized GLP-1S preparation allows consistent evaluation of incretin effects in research settings without variability from undefined mixtures. GLP-1S is intended for research use only.

Analytical Validation and Quality Assurance
Research-grade GLP-1S is supplied at high purity (typically ≥98–99%) and verified by high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to confirm identity and structure.
Products are provided as lyophilized powder in sealed vials with documented peptide content (e.g., 5 mg or 10 mg). This supports standardized use across experiments.

Storage and Stability Guidelines
Correct storage helps maintain the integrity of GLP-1S for reproducible results. Recommended conditions for lyophilized GLP-1S are:

• Room temperature (unopened, lyophilized): Suitable for short periods when kept sealed, dry, and protected from light.

• Refrigerated storage (2–8 °C): Appropriate for unopened or reconstituted material intended for use within days to weeks.

• Frozen storage (≤ −20 °C or lower): Preferred for long-term storage, with vials sealed to prevent moisture uptake and degradation. Reconstituted solutions should be kept cold, protected from light, and used promptly according to standard laboratory practices.

GLP-1S offered by NextGenPeps is intended solely for research use in vitro or in non-human in vivo studies. It may be used in experimental designs focused on metabolic biology, incretin signaling, or related pathways. It is provided strictly for research purposes only and must not be used outside approved laboratory protocols.